Physician profile
Joe Robinson
NPI 1548237027
$2,457.88
in general payments reported to CMS, 2019-2025
13 companies · $15.15 in 2025
The $15.15 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.38 · 2020: $132 · 2021: $1,573 · 2022: $186 · 2023: $285 · 2024: $169 · 2025: $15.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $418 · Education: $50.70.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $418.47 |
| Education | $50.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Research & Development, LLC | $1,500.00 | 2021 | |
| Abbvie INC. | $329.02 | 2023-2024 | Botox |
| Allergan, INC. | $186.01 | 2021-2022 | |
| Astellas Pharma US INC | $125.00 | 2023 | Veozah |
| Coopersurgical, INC. | $100.00 | 2020 | |
| Pfizer INC. | $43.69 | 2019-2020 | |
| Amag Pharmaceuticals, INC. | $41.93 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $41.83 | 2022 | |
| Medtronic USA, INC. | $26.56 | 2019 | |
| Millicent US INC | $17.26 | 2021 | |
| Merck Sharp & Dohme LLC | $16.77 | 2020 | |
| Galderma Laboratories, L.P. | $15.15 | 2025 | Dysport |
| Coloplast Corp | $14.66 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joe Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.